Ausiceft XP 250mg/31.25mg Injection
Marketer
Austex Pharma
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Ausiceft XP 250mg/31.25mg Injection
Cefixime and Sulbactam injection (250mg/31.25mg) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting bacterial growth and halting infection spread. Administration must always be under a doctor's direct supervision; strict adherence to the prescribed dosage schedule is crucial. Complete the full course of treatment, even with symptom improvement, as premature cessation may compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Severe or worsening side effects require immediate medical attention. Allergic reactions (skin rashes, itching, swelling, breathing difficulties) necessitate prompt emergency care. Inform your physician of all current medications, especially if you are pregnant, breastfeeding, or have any underlying health condition. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Rest, proper nutrition, and ample hydration are essential for optimal recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Ausiceft XP 250mg/31.25mg Injection
No text was provided. Please provide the text you wish me to rephrase.
Uses of Ausiceft XP 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ausiceft XP 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ausiceft XP 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ausiceft XP 250mg/31.25mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Ausiceft XP 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam injection (Ausiceft XP 250mg/31.25mg) unites a cephalosporin antibiotic, Ceftriaxone, with the beta-lactamase inhibitor, Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thus hindering bacterial survival. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of Ausiceft XP 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication, Ausiceft XP 250mg/31.25mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingCAUTION
The administration of Ausiceft XP 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the maternal course of treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
The administration of Ausiceft XP 250mg/31.25mg Injection can potentially cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ausiceft XP 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Ausiceft XP (250mg/31.25mg) requires careful administration in individuals with significant hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. However, altering the Ausiceft XP (250mg/31.25mg) injection dose is generally not suggested for those experiencing mild or moderate liver dysfunction.
What if you forget to take Ausiceft XP 250mg/31.25mg Injection :
Should you forget a scheduled dose of Ausiceft XP 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Ausiceft XP 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | Agents against infection |
3,018 People bought this recently